Terms ending in 2030
Every in-force patent on Purdue Pharma L.P.'s record whose computed term ends in 2030, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 9,308,202 | Transdermal Therapeutic System for Administering the Active Substance Buprenorphine In force · High confidence | LTS Lohmann Therapie-Systeme AG | In force | High confidence | |
| US 9,820,983 | Immediate Release Pharmaceutical Compositions Comprising Oxycodone and Naloxone In force · Medium confidence | Purdue Pharma L.P. | In force | Medium confidence | |
| US 9,101,625 | Buprenorphine-Wafer for Drug Substitution Therapy In force · High confidence | Rhodes Pharmaceuticals L.P. | In force | High confidence | |
| US 8,894,987 | Tamper Resistant Dosage Forms In force · High confidence | Knoa Pharma LLC | In force | High confidence | |
| US 8,765,736 | Benzenesulfonamide Compounds and the Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,476,277 | TRPV1 Antagonists Including Dihydroxy Substituent and Uses Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,000,174 | 4-Phenylsulfonamidopiperidines as Calcium Channel Blockers In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 9,040,508 | Compositions of Protein Receptor Tyrosine Kinase Inhibitors In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,429,034 | Inventory Control Over Pharmaceutical Sample Distributions Software, Systems and Methodologies In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| US 8,563,732 | Oxyiimino Compounds and the Use Thereof In force · High confidence | Purdue Pharma L.P. | In force | High confidence | |
| 1 more term end in 2030 · Pro | |||||
10 of 11 patents shown. Soonest term end first, then patent number.
Pro members see all 11.
8 of these are in force and held by Purdue Pharma L.P..
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.